Abvc Biopharma (ABVC) Treasury Shares (2018 - 2026)

Abvc Biopharma (ABVC) has reported Treasury Shares for 2 consecutive years, with -$730049.0 the latest figure, recorded in Q3 2024.

• For the quarter ending Q2 2026, Treasury Shares changed 0.0% year-over-year to $8.9 million; the trailing twelve-month figure through Jun 2026 stood at $8.9 million (changed 0.0% YoY), and the FY2025 full-year result was $8.9 million, changed 0.0% from the prior year.
• Treasury Shares held at $8.9 million in Q2 2026 per ABVC's latest filing, from $8.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $9.1 million in Q1 2022 and bottomed at $8.9 million in Q4 2023.
• Historically, Treasury Shares has averaged $9.0 million across 5 years, with a median of $8.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares decreased 2.18% in 2023, then grew 0.09% in 2024.
• Over 5 years, Treasury Shares stood at $9.1 million in 2022, then decreased by 2.18% to $8.9 million in 2023, then rose by 0.09% to $8.9 million in 2024, then changed by 0.0% to $8.9 million in 2025, then changed by 0.0% to $8.9 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $8.9 million, $8.9 million, and $8.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.